PET-Computed Tomography in Head and Neck Cancer Current Evidence and Future Directions

被引：9
|
作者：
Chen, Yin Jie [1 ]
Rath, Tanya [2 ,3 ]
Mohan, Suyash [4 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Radiol, Hosp Univ Penn, 1 Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Pittsburgh, Sch Med, Dept Radiol, Radiol Adm, PUH Suite E204,200 Lothrop St, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Radiol Adm, PUH Suite E204,200 Lothrop St, Pittsburgh, PA 15213 USA
[4] Univ Penn, Perelman Sch Med, Hosp Univ Penn, Dept Radiol, 219 Dulles Bldg,3400 Spruce St, Philadelphia, PA 19104 USA
来源：
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA | 2018年 / 26卷 / 01期
关键词：
Head and neck; Squamous cell carcinoma; HNSCC; FDG; PET; PET-CT; POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; INTENSITY-MODULATED RADIOTHERAPY; PET/CONTRAST-ENHANCED CT; LYMPH-NODE METASTASES; FDG-PET; F-18-FDG PET/CT; TUMOR HYPOXIA; DISTANT METASTASES; PREDICTIVE-VALUE;
D O I：
10.1016/j.mric.2017.08.003
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Head and neck cancers are among the most common cancers worldwide. More than 90% to 95% are squamous cell carcinomas (SCCs). Accurate staging at diagnosis optimizes treatment planning with improved outcomes. 18F-fluorodeoxyglucose (FDG) PET-computed tomography (CT) has shown tremendous value at diagnosis for accurate staging, treatment planning, and prognostication and after definitive therapy for assessing response and long-term surveillance. Novel non-FDG PET tracers are under investigation, which have great potential for improving patient care in this era of personalized medicine.
引用
收藏
页码：37 / +
页数：14
相关论文
共 50 条
  • [31] Clinical Applications of PET-Computed Tomography in Planning Radiotherapy: General Principles and an Overview
    Kubicek, Gregory J.
    Heron, Dwight E.
    PET CLINICS, 2011, 6 (02) : 105 - +
  • [32] Head and neck cancer: Overview of recent developments and future directions
    Forastiere, AA
    SEMINARS IN ONCOLOGY, 2000, 27 (04) : 1 - 4
  • [33] Immunotherapy for head and neck cancer: Recent advances and future directions
    Cramer, John D.
    Burtness, Barbara
    Ferris, Robert L.
    ORAL ONCOLOGY, 2019, 99
  • [34] Computed tomography-current status and future directions for arthritis imaging
    Ulas, Sevtap Tugce
    Diekhoff, Torsten
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2024, 16
  • [35] FUTURE-DIRECTIONS IN THE CHEMOTHERAPY OF HEAD AND NECK-CANCER
    GRUNBERG, SM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (01): : 51 - 54
  • [36] Chemoprevention of head and neck cancer: present status and future directions
    Chiesa, F.
    ORAL ONCOLOGY, 2007, : 122 - 122
  • [37] Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma
    Lillo, Sara
    Mirandola, Alfredo
    Vai, Alessandro
    Camarda, Anna Maria
    Ronchi, Sara
    Bonora, Maria
    Ingargiola, Rossana
    Vischioni, Barbara
    Orlandi, Ester
    CANCERS, 2024, 16 (11)
  • [38] COMPUTED-TOMOGRAPHY IN THE MANAGEMENT OF HEAD AND NECK-CANCER
    SAGERMAN, RH
    CHUNG, CT
    CT-JOURNAL OF COMPUTED TOMOGRAPHY, 1981, 5 (03): : 229 - 235
  • [39] Spectral Computed Tomography Technique and Applications for Head and Neck Cancer
    Perez-Lara, Almudena
    Forghani, Reza
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2018, 26 (01) : 1 - +
  • [40] THE ROLE OF COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF THE NECK FOLLOWING CHEMORADIOTHERAPY FOR HEAD AND NECK CANCER
    Clavel, S.
    Charron, M. P.
    Belair, M.
    Delouya, G.
    Fortin, B.
    Despres, P.
    Soulieres, D.
    Filion, E.
    Guertin, L.
    Nguyen-Tan, P. F.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S84 - S84
12345